Throughout her career, Una Ryan, Ph.D., has had a knack for understanding the bigger picture — be that as a scientist, a company leader, or even as a campaigner for the biotech industry at large.
From a scientific viewpoint, Dr. Ryan has thrown herself into a variety of research programs at all levels and has easily adapted to different therapeutic categories, continuously seeking out projects that have the potential to save lives.
As a businesswoman, she recognized the value of M&A in the biotech sector before the trend was popular, helping the fledgling company T Cell Sciences move from its focus on complement inhibitors to become a vaccines company, which was renamed Avant Immunotherapeutics and ultimately merged with Celldex.
Perhaps her biggest impact within the biotech industry has been the role she has played in battling for the long-term success of the industry and in particular the influence she was able to bring to bear on the Massachusetts legislature.
“I want to live and work in a state that has science- and business-friendly laws; I don’t believe change just happens, and I believe it’s important to support the industry beyond just my own company’s needs,” she says. “I like to be a part of educational efforts and be involved with groups that can influence the thinking of legislators. I want to work in a healthy industry and I enjoy doing things for the broader group — it’s a rising tide…
A Broader Impact
A Watershed Career Transition